Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

(2022) Shadi Yaghi et al.   STROKE

Antithrombotic Therapy for VTE Disease

(2021) Scott M. Stevens et al.   CHEST

A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis

(2020) Marissa Powell et al.   ANNALS OF PHARMACOTHERAPY

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis

(2019) José M. Ferro et al.   JAMA Neurology

Apixaban and rivaroxaban in patients with cerebral venous thrombosis

(2018) Fahrettin Covut et al.   THROMBOSIS RESEARCH

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology

(2017) J. M. Ferro et al.   EUROPEAN JOURNAL OF NEUROLOGY

Apixaban for the treatment of cerebral venous thrombosis: A case series

(2017) Shishir Keekana Rao et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebral Venous Thrombosis

(2015) Salma I. Patel et al.   NEUROLOGIST

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and Management of Cerebral Venous Thrombosis

(2011) Gustavo Saposnik et al.   STROKE